Yiyi Huang Selected Research

Exenatide (Byetta)

12/2015

Exendin-4 attenuates cardiac hypertrophy via AMPK/mTOR signaling pathway activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yiyi Huang Research Topics

Disease

1	Granuloma 01/2017
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2017
1	Cardiomegaly (Heart Hypertrophy) 12/2015
1	Ventricular Remodeling 01/2009
1	Myocardial Infarction 01/2009
1	Heart Failure 01/2009

Drug/Important Bio-Agent (IBA)

1	Carbon Nanotubes (Carbon Nanotube)IBA 01/2017
1	NF-kappa B (NF-kB)IBA 01/2017
1	Atrial Natriuretic Factor (ANF)IBA 12/2015
1	Glucagon-Like Peptide-1 ReceptorIBA 12/2015
1	Exenatide (Byetta)FDA Link 12/2015
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 12/2015
1	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2015
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2009
1	salicylhydroxamic acid (SHAM)IBA 01/2009

Therapy/Procedure

1	Intravenous Injections 01/2017
1	Intravenous Administration 01/2017